Probiotics in reducing anxiety and depression symptoms: an integrative review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Revista Ciências em Saúde |
DOI: | 10.21876/rcshci.v10i4.1014 |
Texto Completo: | https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014 |
Resumo: | Objectives: To summarize studies that evaluated probiotic supplementation as a therapeutic strategy for anxiety and depression symptoms. Methods: An integrative review of articles indexed in the PubMed, SciELO and Virtual Health Library databases published between January 2010 and September 2019. For this purpose, the combination of descriptors: “intestine”, “brain”, “Intestinal microbiota”, “anxiety”, “depression”, “probiotics”, in Portuguese and English. Results: After applying the inclusion and exclusion criteria, 13 randomized clinical trials were selected. The duration of the studies in its majority was 8 or 12 weeks (61.5%; n = 8), and the most offered form of the supplement was the probiotic powder (46.2%; n = 6) and capsule (30.8%; n = 4). Regarding the use of scales as a parameter for assessing symptoms of anxiety and depression, 38.5% (n = 5) used only one scale and 69.2% (n = 8) used the combination of two or three scales. Regarding the genus of bacteria, most studies used Lactobacillus and Bifidobacterium together (53.8%; n = 7). Despite methodological limitations and inconsistent results, most clinical trials (76.92%; n = 10) showed a significant reduction in symptoms related to anxiety and depression through probiotic supplementation. Conclusion: The evidence indicates that supplementation with probiotics has a potential in reducing symptoms of anxiety and depression, however further research is needed on this strategy as an adjunctive therapy in effective treatment for mental health. |
id |
RCS_e4bcbe79b8e8c78235fda356f5080f64 |
---|---|
oai_identifier_str |
oai:ojs.portalrcs.hcitajuba.org.br:article/1014 |
network_acronym_str |
RCS |
network_name_str |
Revista Ciências em Saúde |
spelling |
Probiotics in reducing anxiety and depression symptoms: an integrative reviewProbióticos na redução de sintomas de ansiedade e depressão: uma revisão integrativaanxietydepressionintestinal microbiotaprobioticsansiedadedepressãomicrobiota intestinalprobióticosObjectives: To summarize studies that evaluated probiotic supplementation as a therapeutic strategy for anxiety and depression symptoms. Methods: An integrative review of articles indexed in the PubMed, SciELO and Virtual Health Library databases published between January 2010 and September 2019. For this purpose, the combination of descriptors: “intestine”, “brain”, “Intestinal microbiota”, “anxiety”, “depression”, “probiotics”, in Portuguese and English. Results: After applying the inclusion and exclusion criteria, 13 randomized clinical trials were selected. The duration of the studies in its majority was 8 or 12 weeks (61.5%; n = 8), and the most offered form of the supplement was the probiotic powder (46.2%; n = 6) and capsule (30.8%; n = 4). Regarding the use of scales as a parameter for assessing symptoms of anxiety and depression, 38.5% (n = 5) used only one scale and 69.2% (n = 8) used the combination of two or three scales. Regarding the genus of bacteria, most studies used Lactobacillus and Bifidobacterium together (53.8%; n = 7). Despite methodological limitations and inconsistent results, most clinical trials (76.92%; n = 10) showed a significant reduction in symptoms related to anxiety and depression through probiotic supplementation. Conclusion: The evidence indicates that supplementation with probiotics has a potential in reducing symptoms of anxiety and depression, however further research is needed on this strategy as an adjunctive therapy in effective treatment for mental health.Objetivos: sumarizar estudos que avaliaram a suplementação de probióticos como estratégia terapêutica nos sintomas da ansiedade e depressão. Métodos: revisão integrativa de artigos indexados na base de dados PubMed, SciELO e Biblioteca Virtual em Saúde publicados de janeiro de 2010 a setembro de 2019. Para isso, utilizou-se a conjugação dos descritores: “intestino”, “cérebro”, “microbiota intestinal”, “ansiedade”, “depressão”, “probióticos”, nos idiomas português e inglês. Resultados: Após a aplicação dos critérios de inclusão e exclusão, 13 ensaios clínicos randomizados foram selecionados. O tempo de duração dos estudos, em sua maioria, foi de 8 ou 12 semanas (61,5%; n = 8), e a forma mais ofertada do suplemento foi o probiótico em pó (46,2%; n = 6) e em cápsula (30,8%; n = 4). Sobre a utilização de escalas como parâmetro de avaliação dos sintomas de ansiedade e depressão, 38,5% (n = 5) utilizaram apenas uma escala e 69,2% (n = 8) utilizaram a combinação de duas ou três escalas. Em relação ao gênero das bactérias, a maior parte dos estudos utilizou Lactobacillus e Bifidobacterium em conjunto (53,8%; n = 7). Apesar das limitações metodológicas e dos resultados inconsistentes, a maioria dos ensaios clínicos (76,9%; n = 10) evidenciaram uma redução significativa dos sintomas relacionados à ansiedade e depressão através da suplementação de probióticos. Conclusão: As evidências indicam que a suplementação com probióticos apresenta potencial promissor na redução dos sintomas de ansiedade e depressão, no entanto são necessárias pesquisas adicionais sobre essa estratégia como terapia adjuvante no tratamento efetivo para a saúde mental.AISI/HCI2020-12-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer reviewedAvaliado pelos parestextoinfo:eu-repo/semantics/otherapplication/pdftext/htmltext/xmlhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/101410.21876/rcshci.v10i4.1014Revista Ciências em Saúde; v. 10 n. 4 (2020): Outubro a Dezembro de 2020; 97-108Health Sciences Journal; Vol 10 No 4 (2020): October to December 2020; 97-1082236-378510.21876/rcshci.v10i4reponame:Revista Ciências em Saúdeinstname:Hospital de Clínicas de Itajubáinstacron:HCIporhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014/619https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014/654https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014/655Copyright (c) 2020 Revista Ciências em Saúdehttps://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessCosta, Bruna CunhaAzevedo, George Silva dos SantosFerreira, Pedro Henrique ArrudaRodrigues Almeida, Leila Magda2021-01-16T05:06:29Zoai:ojs.portalrcs.hcitajuba.org.br:article/1014Revistahttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zeroPUBhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/oaircs@hcitajuba.org.br||rcsfmit@medicinaitajuba.com.br2236-37852236-3785opendoar:2021-01-16T05:06:29Revista Ciências em Saúde - Hospital de Clínicas de Itajubáfalse |
dc.title.none.fl_str_mv |
Probiotics in reducing anxiety and depression symptoms: an integrative review Probióticos na redução de sintomas de ansiedade e depressão: uma revisão integrativa |
title |
Probiotics in reducing anxiety and depression symptoms: an integrative review |
spellingShingle |
Probiotics in reducing anxiety and depression symptoms: an integrative review Probiotics in reducing anxiety and depression symptoms: an integrative review Costa, Bruna Cunha anxiety depression intestinal microbiota probiotics ansiedade depressão microbiota intestinal probióticos Costa, Bruna Cunha anxiety depression intestinal microbiota probiotics ansiedade depressão microbiota intestinal probióticos |
title_short |
Probiotics in reducing anxiety and depression symptoms: an integrative review |
title_full |
Probiotics in reducing anxiety and depression symptoms: an integrative review |
title_fullStr |
Probiotics in reducing anxiety and depression symptoms: an integrative review Probiotics in reducing anxiety and depression symptoms: an integrative review |
title_full_unstemmed |
Probiotics in reducing anxiety and depression symptoms: an integrative review Probiotics in reducing anxiety and depression symptoms: an integrative review |
title_sort |
Probiotics in reducing anxiety and depression symptoms: an integrative review |
author |
Costa, Bruna Cunha |
author_facet |
Costa, Bruna Cunha Costa, Bruna Cunha Azevedo, George Silva dos Santos Ferreira, Pedro Henrique Arruda Rodrigues Almeida, Leila Magda Azevedo, George Silva dos Santos Ferreira, Pedro Henrique Arruda Rodrigues Almeida, Leila Magda |
author_role |
author |
author2 |
Azevedo, George Silva dos Santos Ferreira, Pedro Henrique Arruda Rodrigues Almeida, Leila Magda |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Costa, Bruna Cunha Azevedo, George Silva dos Santos Ferreira, Pedro Henrique Arruda Rodrigues Almeida, Leila Magda |
dc.subject.por.fl_str_mv |
anxiety depression intestinal microbiota probiotics ansiedade depressão microbiota intestinal probióticos |
topic |
anxiety depression intestinal microbiota probiotics ansiedade depressão microbiota intestinal probióticos |
description |
Objectives: To summarize studies that evaluated probiotic supplementation as a therapeutic strategy for anxiety and depression symptoms. Methods: An integrative review of articles indexed in the PubMed, SciELO and Virtual Health Library databases published between January 2010 and September 2019. For this purpose, the combination of descriptors: “intestine”, “brain”, “Intestinal microbiota”, “anxiety”, “depression”, “probiotics”, in Portuguese and English. Results: After applying the inclusion and exclusion criteria, 13 randomized clinical trials were selected. The duration of the studies in its majority was 8 or 12 weeks (61.5%; n = 8), and the most offered form of the supplement was the probiotic powder (46.2%; n = 6) and capsule (30.8%; n = 4). Regarding the use of scales as a parameter for assessing symptoms of anxiety and depression, 38.5% (n = 5) used only one scale and 69.2% (n = 8) used the combination of two or three scales. Regarding the genus of bacteria, most studies used Lactobacillus and Bifidobacterium together (53.8%; n = 7). Despite methodological limitations and inconsistent results, most clinical trials (76.92%; n = 10) showed a significant reduction in symptoms related to anxiety and depression through probiotic supplementation. Conclusion: The evidence indicates that supplementation with probiotics has a potential in reducing symptoms of anxiety and depression, however further research is needed on this strategy as an adjunctive therapy in effective treatment for mental health. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-12-14 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer reviewed Avaliado pelos pares texto info:eu-repo/semantics/other |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014 10.21876/rcshci.v10i4.1014 |
url |
https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014 |
identifier_str_mv |
10.21876/rcshci.v10i4.1014 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014/619 https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014/654 https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014/655 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2020 Revista Ciências em Saúde https://creativecommons.org/licenses/by-nc-sa/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2020 Revista Ciências em Saúde https://creativecommons.org/licenses/by-nc-sa/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf text/html text/xml |
dc.publisher.none.fl_str_mv |
AISI/HCI |
publisher.none.fl_str_mv |
AISI/HCI |
dc.source.none.fl_str_mv |
Revista Ciências em Saúde; v. 10 n. 4 (2020): Outubro a Dezembro de 2020; 97-108 Health Sciences Journal; Vol 10 No 4 (2020): October to December 2020; 97-108 2236-3785 10.21876/rcshci.v10i4 reponame:Revista Ciências em Saúde instname:Hospital de Clínicas de Itajubá instacron:HCI |
instname_str |
Hospital de Clínicas de Itajubá |
instacron_str |
HCI |
institution |
HCI |
reponame_str |
Revista Ciências em Saúde |
collection |
Revista Ciências em Saúde |
repository.name.fl_str_mv |
Revista Ciências em Saúde - Hospital de Clínicas de Itajubá |
repository.mail.fl_str_mv |
rcs@hcitajuba.org.br||rcsfmit@medicinaitajuba.com.br |
_version_ |
1822179480788008960 |
dc.identifier.doi.none.fl_str_mv |
10.21876/rcshci.v10i4.1014 |